The 7th annual Patients as Partners is guided by a dedicated group of advisors from pharma and biotech, patient advocacy and FDA whom meet quarterly to develop the conference agenda. This is the only event that truly demonstrates how to involve patients throughout the entire medicines development life cycle to drive greater efficiencies in clinical research.The program delves deep into patient involvement ideas, strategies and implementation processes that biopharma can utilize in order to help advance patient participation for better clinical outcomes. Each session demonstrates the what, where, when and how to co-create solutions with patients and measure the impact of those initiatives.
Key Topic Areas Include:
- BioPharma Strategies on Applying Patient Engagement Initiatives and Demonstrating Impact
- Direct-to-Patient Clinical Trials Next Milestones and Actions to Get There
- Measuring the Impact of Patient Engagement and Patient Centricity in Clinical Research and Development
- Current Efforts for Educating and Raising Awareness in Clinical Trials
- Strategies for Increased Inclusion of Racial and Ethnic Minorities in Clinical Trials
- Progress on Patient Data Ownership
- Collaborating with Site Partners And CROs to Increase Efficiencies, Provide Greater Access and Value to Patients and Clinical Trials
- Progress on the National Health Council's Patient Engagement Fair Market Value Initiative
- FDA Reports on the Latest Guidance Updates and New Agency Efforts on Patient Engagement
Key Topic Areas Include:
- BioPharma Strategies on Applying Patient Engagement Initiatives and Demonstrating Impact
- Direct-to-Patient Clinical Trials Next Milestones and Actions to Get There
- Measuring the Impact of Patient Engagement and Patient Centricity in Clinical Research and Development
- Current Efforts for Educating and Raising Awareness in Clinical Trials
- Strategies for Increased Inclusion of Racial and Ethnic Minorities in Clinical Trials
- Progress on Patient Data Ownership
- Collaborating with Site Partners And CROs to Increase Efficiencies, Provide Greater Access and Value to Patients and Clinical Trials
- Progress on the National Health Council's Patient Engagement Fair Market Value Initiative
- FDA Reports on the Latest Guidance Updates and New Agency Efforts on Patient Engagement
